Case report reveals that anti-lactosylceramide antibodies and electrophysiological studies aid in diagnosing encephalomyeloradiculopathy, highlighting therapeutic effects.
A 71-year-old woman developed progressive limb weakness and sensory disturbances below the thoracic level. Although myelopathy was initially considered, spinal magnetic resonance imaging (MRI) showed no abnormalities. Conversely, electrophysiological studies have identified both spinal dysfunction and radiculopathy, suggesting myeloradiculopathy. Initiation of steroid therapy resulted in immediate improvement of clinical symptoms and electrophysiological findings. Finally, anti-lactosylceramide (LacCer) antibodies were detected in the serum and cerebrospinal fluid, and titer changes correlated well with clinical improvement. This case suggests that electrophysiological studies and anti-LacCer antibodies are helpful in diagnosing and evaluating the therapeutic effects in cases of MRI-negative encephalomyeloradiculopathy.
No takes yet. Share an insight, caveat, or question.
Fujioka et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: